id: topiramate_treatment_to_body_mass_index
name: Topiramate Pharmacotherapy â†’ Body Mass Index
from_node:
  node_id: topiramate_treatment
  node_name: Topiramate Pharmacotherapy
to_node:
  node_id: body_mass_index
  node_name: Body Mass Index
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Topiramate has known effects on appetite regulation and metabolic pathways'
- 'Step 2: Medication reduces caloric intake from both food and alcohol consumption'
- 'Step 3: Decreased alcohol consumption specifically eliminates high-calorie alcohol
  intake'
- 'Step 4: Combined effects lead to reduction in body mass index over treatment period'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Kirsten C Morley et al. 2024. "Topiramate Versus Naltrexone for
    Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled
    Trial.." *American Journal of Psychiatry*. https://doi.org/10.1176/appi.ajp.20230666'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.665325'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
